Northern Trust’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-30,251
| Closed | -$12K | – | 4635 |
|
|
2023
Q3 | $12K | Sell |
30,251
-7,970
| -21% | -$3.93K | ﹤0.01% | 4388 |
|
|
2023
Q2 | $26.4K | Buy |
38,221
+8,086
| +27% | +$52.1K | ﹤0.01% | 4353 |
|
|
2023
Q1 | $238K | Buy |
30,135
+2,038
| +7% | +$7.1K | ﹤0.01% | 3784 |
|
|
2022
Q4 | $25.3K | Hold |
28,097
| – | – | ﹤0.01% | 4437 |
|
|
2022
Q3 | $31K | Hold |
28,097
| – | – | ﹤0.01% | 4458 |
|
|
2022
Q2 | $35K | Hold |
28,097
| – | – | ﹤0.01% | 4519 |
|
|
2022
Q1 | $66K | Sell |
28,097
-8,313
| -23% | -$19.8K | ﹤0.01% | 4468 |
|
|
2021
Q4 | $113K | Sell |
36,410
-243
| -0.7% | -$807 | ﹤0.01% | 4384 |
|
|
2021
Q3 | $149K | Buy |
36,653
+98
| +0.3% | +$408 | ﹤0.01% | 4284 |
|
|
2021
Q2 | $177K | Sell |
36,555
-39,024
| -52% | -$175K | ﹤0.01% | 4203 |
|
|
2021
Q1 | $393K | Sell |
75,579
-14,028
| -16% | -$97.7K | ﹤0.01% | 3895 |
|
|
2020
Q4 | $598K | Sell |
89,607
-2,619
| -3% | -$21.4K | ﹤0.01% | 3679 |
|
|
2020
Q3 | $938K | Buy |
92,226
+2,141
| +2% | +$25.2K | ﹤0.01% | 3419 |
|
|
2020
Q2 | $1.13M | Buy |
+90,085
| New | +$1.26M | ﹤0.01% | 3311 |
|
|
2020
Q1 | – | Sell |
-5,085
| Closed | -$27K | – | 4316 |
|
|
2019
Q4 | $27K | Hold |
5,085
| – | – | ﹤0.01% | 4129 |
|
|
2019
Q3 | $37K | Hold |
5,085
| – | – | ﹤0.01% | 4086 |
|
|
2019
Q2 | $46K | Hold |
5,085
| – | – | ﹤0.01% | 4095 |
|
|
2019
Q1 | $50K | Buy |
5,085
+981
| +24% | +$10.8K | ﹤0.01% | 4039 |
|
|
2018
Q4 | $49K | Sell |
4,104
-24
| -0.6% | -$348 | ﹤0.01% | 4056 |
|
|
2018
Q3 | $66K | Sell |
4,128
-177
| -4% | -$4.21K | ﹤0.01% | 4093 |
|
|
2018
Q2 | $156K | Hold |
4,305
| – | – | ﹤0.01% | 3915 |
|
|
2018
Q1 | $134K | Buy |
4,305
+357
| +9% | +$11.4K | ﹤0.01% | 3907 |
|
|
2017
Q4 | $153K | Sell |
3,948
-15
| -0.4% | -$393 | ﹤0.01% | 3890 |
|
|
2017
Q3 | $84K | Buy |
3,963
+97
| +3% | +$1.8K | ﹤0.01% | 3992 |
|
|
2017
Q2 | $78K | Hold |
3,866
| – | – | ﹤0.01% | 4021 |
|
|
2017
Q1 | $86K | Buy |
+3,866
| New | +$60.8K | ﹤0.01% | 3991 |
|
Other funds holding BLPH
Northern Trust's BLPH Position: Q4 2023 in Review
Northern Trust sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q4 2023, closing a stake of 30,251 shares — an estimated $12K sold.
Northern Trust first reported a position in BLPH in Q1 2017 and held it in 26 quarters. The position peaked at $1.13M in Q2 2020. 2 funds tracked by Wall St. Rank hold BLPH as of Q4 2023.
- Northern Trust reported no remaining Bellerophon Therapeutics, Inc. position as of Q4 2023 after selling out during the quarter.
- Northern Trust sold 30,251 Bellerophon Therapeutics, Inc. shares in Q4 2023, an estimated $12K.
- Northern Trust first reported a position in Bellerophon Therapeutics, Inc. in Q1 2017 and held it in 26 quarters.
- Northern Trust's Bellerophon Therapeutics, Inc. position peaked at $1.13M in Q2 2020.
- 2 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q4 2023.
Based on Northern Trust's 13F filing for Q4 2023, filed 13 Feb 2024.